Priority 8 Sight Loss and Vision PSP Ocular Inflammatory Disease
UNCERTAINTY: What medications best prevent the development of eye disease in Behcets? (JLA PSP Priority 8) | |
---|---|
Overall ranking | 8 |
JLA question ID | 0014h/8 |
Explanatory note | Relevant reliable up-to-date systematic reviews do not address continuing uncertainties about treatment effects |
Evidence | None identified |
Health Research Classification System category | Eye |
Extra information provided by this PSP | |
---|---|
Original uncertainty examples | None provided |
Systematic reviews that need updating or extending | Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD005556. DOI: 10.1002/14651858.CD005556.pub2 |
Systematic reviews in preparation (at time of PSP) |
None identified |
Ongoing controlled trials | Evaluation du traitement par corticoth?rapie syst?mique ou par interf?ron alpha2a au cours de la Birdshot r?tinochoro?dopathie compliqu?e d'oedeme maculaire https://www.clinicaltrialsregister.eu/ctr-search/search? query=eudract_number:2006-003002-26 |
Submitted by | Clinicians |
Outcomes to be measured | Incidence of Behcets: adverse effects or complications; acceptability to patients or carers; time to return to work or normal activity; time in hospital and or needing health or social care services; health related quality of life; and costs |
PSP information | |
---|---|
PSP unique ID | 0014h |
PSP name | Sight Loss and Vision - Ocular Inflammatory Disease |
Total number of uncertainties identified by this PSP. | 108 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
Date of priority setting workshop | April and May 2013 |